CLINICAL_TRIALS
withdrawal
· 2014-05-05
Clinical Trial Update: Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma [Phase 2]
Summary
The Phase 2 trial of sunitinib malate for East African patients with AIDS-related Kaposi sarcoma or Classic Kaposi sarcoma has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: AIDS-related Kaposi Sarcoma, Classic Kaposi Sarcoma | Phase 2 | Status: WITHDRAWN